Biogen shares soar 32% on MS drug patent win over Mylan

Biogen Inc's shares surged as much as 32% on Wednesday after the drugmaker won a favorable U.S. patent ruling for its main multiple sclerosis drug Tecfidera in a battle with Mylan NV.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news